BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 962991)

  • 21. Review: dendritic cell immunotherapy for melanoma.
    Hadzantonis M; O'Neill H
    Cancer Biother Radiopharm; 1999 Feb; 14(1):11-22. PubMed ID: 10850282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-tumour immunity in malignant melanoma assay by tube leucocyte adherence inhibition.
    Marti JH; Thomson DM
    Br J Cancer; 1976 Aug; 34(2):116-33. PubMed ID: 962991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tube leukocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. "Blockade" of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients.
    Grosser N; Thompson DM
    Int J Cancer; 1976 Jul; 18(1):58-66. PubMed ID: 59711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An overview: antitumor immunity in breast cancer assayed by tube leukocyte adherence inhibition.
    Flores M; Marti JH; Grosser N; MacFarlane JK; Thomson DM
    Cancer; 1977 Feb; 39(2):494-505. PubMed ID: 319891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigen via cytophilic anti-tumour antibody.
    Marti JH; Grosser N; Thomson DM
    Int J Cancer; 1976 Jul; 18(1):48-57. PubMed ID: 947860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
    Okada Y
    Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein measurement with the Folin phenol reagent.
    LOWRY OH; ROSEBROUGH NJ; FARR AL; RANDALL RJ
    J Biol Chem; 1951 Nov; 193(1):265-75. PubMed ID: 14907713
    [No Abstract]   [Full Text] [Related]  

  • 29. Cancer cells in the blood; a five to nine year follow up study.
    ENGELL HC
    Ann Surg; 1959 Apr; 149(4):457-61. PubMed ID: 13637653
    [No Abstract]   [Full Text] [Related]  

  • 30. Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal.
    Barski G; Youn JK
    J Natl Cancer Inst; 1969 Jul; 43(1):111-21. PubMed ID: 5796377
    [No Abstract]   [Full Text] [Related]  

  • 31. Delayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.
    Oren ME; Herberman RB
    Clin Exp Immunol; 1971 Jul; 9(1):45-56. PubMed ID: 5559094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative depression of tumour-directed cell-mediated immunity in patients with malignant disease.
    Cochran AJ; Spilg WG; Mackie RM; Thomas CE
    Br Med J; 1972 Oct; 4(5832):67-70. PubMed ID: 5077468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune factors in human cancer: malignant melanomas, skeletal and soft tissue sarcomas.
    Morton DL; Eilber FR; Malmgren RA
    Prog Exp Tumor Res; 1971; 14():25-42. PubMed ID: 5002728
    [No Abstract]   [Full Text] [Related]  

  • 34. Cellular and humoral immunity against human malignant melanoma.
    Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
    Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunization with irradiated tumour cells and specific lymphocyte cytotoxicity in malignant melanoma.
    Currie GA; Lejeune F; Fairley GH
    Br Med J; 1971 May; 2(5757):305-10. PubMed ID: 4930209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.
    Lewis MG; Ikonopisov RL; Nairn RC; Phillips TM; Fairley GH; Bodenham DC; Alexander P
    Br Med J; 1969 Sep; 3(5670):547-52. PubMed ID: 4896110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immunity and specific serum factors in human cancer: the leukocyte adherence inhibition test.
    Maluish A; Halliday WJ
    J Natl Cancer Inst; 1974 May; 52(5):1415-20. PubMed ID: 4831432
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.